n/a
Article Publish Status: FREE
Abstract Title:

Antihyperalgesic activity of verbascoside in two models of neuropathic pain.

Abstract Source:

J Pharm Pharmacol. 2011 Apr ;63(4):594-601. Epub 2011 Mar 8. PMID: 21401613

Abstract Author(s):

Benedetta Isacchi, Romina Iacopi, Maria Camilla Bergonzi, Carla Ghelardini, Nicoletta Galeotti, Monica Norcini, Elisa Vivoli, Franco Francesco Vincieri, Anna Rita Bilia

Article Affiliation:

Benedetta Isacchi

Abstract:

OBJECTIVES: This study reports on the rapid isolation of verbascoside from Lippia citriodora H.B.K. (Verbenaceae), an inexpensive and widespread source, and the evaluation of its antihyperalgesic activity.

METHODS: Isolation of verbascoside was achieved by size exclusion chromatography with Sephadex LH-20 eluting with 50% EtOH, which is proposed as a fast and efficient method of separation.

KEY FINDINGS: The antihyperalgesic activity of verbascoside was tested by in-vivo assay using the paw-pressure test in two animal models of neuropathic pain: a peripheral mononeuropathy produced either by a chronic constriction injury of the sciatic nerve (CCI) or by an intra-articular injection of sodium monoiodoacetate (MIA).

CONCLUSIONS: Verbascoside administered intraperitoneally at a dose of 100 mg/kg reverted the mechanical hyperalgesia in both CCI and MIA treated rats, as evaluated in the paw-pressure test. Verbascoside was also effective against mechanical hyperalgesia after oral administration at doses of 300 and 600 mg/kg.

Study Type : Animal Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.